Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
{{output}}
Background: Imlunestrant is a next-generation, brain-penetrant, oral selective estrogen-receptor (ER) degrader that delivers continuous ER inhibition, even in cancers with mutations in the gene encoding ERα (ESR1). ... ...
